OPRX (OptimizeRx) Short-Term Debt: $2.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OPRX OptimizeRx Corp OPRX
59 GF Score
Price $6.70
GF Value $12.89
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is OptimizeRx Short-Term Debt?

OptimizeRx OPRX +0.45% 59 Short-Term Debt is $2.0 Mil as of Mar. 2026. GuruFocus rates OPRX with a GF Score™ of 59/100 and a GF Value™ of $12.89 (Significantly Undervalued). The stock has 3 warning signs investors should review.

OptimizeRx's Short-Term Debt for the quarter that ended in Mar. 2026 was $2.0 Mil.

OptimizeRx's quarterly Short-Term Debt increased from Sep. 2025 ($3.3 Mil) to Dec. 2025 ($4.3 Mil) but then declined from Dec. 2025 ($4.3 Mil) to Mar. 2026 ($2.0 Mil).

OptimizeRx's annual Short-Term Debt stayed the same from Dec. 2023 ($2.0 Mil) to Dec. 2024 ($2.0 Mil) but then increased from Dec. 2024 ($2.0 Mil) to Dec. 2025 ($4.3 Mil).

OptimizeRx Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

OptimizeRx Short-Term Debt Related Terms

OptimizeRx Short-Term Debt Historical Data

* Premium members only.

The historical data trend for OptimizeRx's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OptimizeRx Short-Term Debt Chart

OptimizeRx Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 2.00 2.00 4.26

OptimizeRx Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.30 3.30 3.30 4.26 2.00
OPRX
59GF Score
OptimizeRx Corp OPRX
Short-Term Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of $2.0 Mil mean?
OptimizeRx (OPRX) has a Short-Term Debt of $2.0 Mil as of Mar. 2026.
Is OptimizeRx's Short-Term Debt too high?
OptimizeRx's current Short-Term Debt is $2.0 Mil. Overall, OptimizeRx has a GF Score™ of 59/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does OptimizeRx's Short-Term Debt compare to CCLD and DH?
OptimizeRx's Short-Term Debt of $2.0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Healthcare Providers & Services company?
A good Short-Term Debt depends on the Healthcare Providers & Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. OptimizeRx's current Short-Term Debt is $2.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OptimizeRx stock overvalued right now?
Based on GuruFocus' analysis, OptimizeRx (OPRX) is currently considered Significantly Undervalued. The stock's GF Value™ is $12.89, compared to a current price of $6.70 — trading 48.1% below its estimated fair value. The current Short-Term Debt is $2.0 Mil. OptimizeRx's overall GF Score™ is 59/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For OptimizeRx (OPRX), the current Short-Term Debt is $2.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OptimizeRx (OPRX) Overvalued in 2026?

Based on GuruFocus' analysis, OptimizeRx stock appears to be undervalued. The current stock price of $6.70 is trading 48.1% below its estimated GF Value™ of $12.89. GuruFocus considers OptimizeRx to be Significantly Undervalued.

Key valuation signals for OPRX:

  • Short-Term Debt: $2.0 Mil
  • GF Value™: $12.89 vs. price of $6.70 (48.1% below fair value)
  • GF Score™: 59/100 with 3 warning signs

No single metric tells the full story. See the OPRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OptimizeRx Business Description

Address 260 Charles Street, Suite 302, Waltham, MA, USA, 02453
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
59GF Score

Get the complete analysis for OPRX

Short-Term Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.70
Price
$12.89
GF Value